Brown adipose tissue has captivated metabolism scientists for decades due to its unique thermogenic abilities. Unlike white fat, which primarily stores energy, brown fat specializes in burning calories to generate heat, a process termed non-shivering thermogenesis. This heat production is crucial not only for maintaining body temperature in cold environments but also plays a role in systemic metabolic processes, including glucose regulation. Despite insights into BAT’s metabolic functions, how the sympathetic nervous system orchestrates these responses through precise neural pathways remained elusive—until now.

The research, conducted by Neri, Lee, Fohn, and colleagues, reveals that sympathetic projections to BAT are not monolithic but rather consist of distinct populations of neurons with discrete functional roles. Using cutting-edge neuroanatomical tracing, optogenetics, and metabolic phenotyping, the investigators mapped these pathways with unparalleled clarity. They demonstrated that one set of sympathetic neurons predominantly regulates BAT-mediated thermogenesis, while another set modulates glucose tolerance—thereby dissociating two fundamental metabolic functions attributable to brown fat.

This dualistic neural control model signifies a paradigm shift. It suggests that the sympathetic nervous system exerts differentiated control over thermogenic activation and endocrine-metabolic adaptations, rather than a single, uniform output. This nuanced regulation involves distinct circuits emerging from separate nodes in the central nervous system and converging onto BAT, each modulating specific downstream metabolic outcomes. Such specificity offers potential therapeutic leverage points to selectively boost thermogenesis or improve glucose metabolism in metabolic diseases.

Detailed neuroanatomical analyses identified key brainstem and hypothalamic regions as origins of these specialized sympathetic projections. Importantly, these divergent pathways exhibited characteristic molecular markers, underscoring their unique identities. For instance, neurons governing thermogenesis displayed heightened expression of adrenergic receptor components, essential for activating BAT’s heat-producing machinery. Conversely, neurons implicated in glucose regulation interfaced with systemic metabolic networks, influencing insulin sensitivity and glucose uptake dynamics.

Functionally, optogenetic stimulation experiments substantiated the dissociation of these circuits. Selective activation of thermogenesis-related sympathetic pathways led to increased energy expenditure and heat production without significantly affecting systemic glucose metrics. Conversely, stimulating glucose-modulatory projections improved glucose tolerance independently of thermogenic changes. This functional delineation deepens our mechanistic understanding of the sympathetic control over metabolic tissues.

Importantly, the study employed a rodent model of diet-induced obesity to probe translational relevance. In this context, selective modulation of the glucose-regulating sympathetic pathway ameliorated hyperglycemia and insulin resistance, demonstrating therapeutic potential. The capacity to target discrete sympathetic outputs may pave the way for next-generation interventions aimed at distinct metabolic endpoints, bypassing the side effects associated with broad sympathetic activation.

At a cellular level, the team explored how sympathetic neurotransmitters interact with adipocyte receptors within BAT. They found that noradrenaline released from thermogenesis-specific neurons robustly activated uncoupling protein 1 (UCP1), driving mitochondrial heat production. Meanwhile, the glucose-control circuit modulated adipocyte insulin sensitivity through alternative adrenergic signaling cascades, highlighting complex intercellular communication mechanisms that orchestrate systemic metabolism.

This research also challenges current dogma by suggesting that the sympathetic nervous system’s influence extends beyond immediate metabolic toggling. It appears capable of inducing long-term adaptations in brown adipose tissue function and systemic glucose homeostasis. Such plasticity implies that sympathetic circuits may be amenable to reprogramming or fine-tuning as a durable therapeutic strategy against obesity and type 2 diabetes.

Furthermore, the elucidation of these distinct pathways enriches our understanding of brown fat’s physiological heterogeneity. Brown adipocytes have been traditionally viewed as a uniform cell type, but this study suggests that their functional diversity partly reflects the differential sympathetic innervation patterns they receive. This finding invites further exploration into the interplay between neural inputs and adipose tissue phenotypes.

The authors also discuss the implications of their findings in the context of human health. Given that brown fat activity inversely correlates with obesity and metabolic disease in humans, decoding the neuronal control mechanisms offers a translational bridge towards targeted neuromodulatory therapies. Precision interventions that selectively amplify thermogenesis could enhance energy expenditure, while those that improve BAT-driven glucose clearance could mitigate hyperglycemia without impacting thermal regulation.

Future directions proposed by the researchers include delineating the molecular signals that specify sympathetic neuron subtype identities during development and adulthood, as well as investigating how these circuits adapt to environmental stimuli such as cold exposure or dietary shifts. Such work will deepen insights into the dynamic regulation of energy balance by neuro-metabolic networks.

The study’s methodological advancements are also noteworthy. By integrating viral tracing techniques with in vivo neural manipulation and sophisticated metabolic assays, the research sets new standards for dissecting neuro-adipose tissue crosstalk. This multimodal approach promises to accelerate discoveries in the emerging field of neuro-metabolism, fostering innovations to combat metabolic diseases at the neural circuit level.

Ultimately, the identification of functionally distinct sympathetic projections controlling BAT thermogenesis and glucose tolerance marks a milestone in metabolism research. It underlines the complexity of sympathetic outputs and gently overturns simplistic views of autonomic regulation. As we unearth the molecular and circuit-based architecture underpinning metabolic control, we edge closer to novel therapies that harness the body’s own neural networks to restore and maintain metabolic health.

This landmark discovery opens a new chapter in metabolic neuroscience, promising to inspire a wave of innovative research focused on exploiting symmetrically specialized neural circuits. By bridging the gap between brain, fat, and systemic metabolism, we stand on the cusp of transformative advances that could dramatically reshape how metabolic diseases are treated in the years to come.

Subject of Research: Sympathetic nervous system regulation of brown adipose tissue thermogenesis and glucose metabolism.

Article Title: Distinct sympathetic projections to brown fat regulate thermogenesis and glucose tolerance.

Article References:
Neri, D., Lee, S., Fohn, A.M. et al. Distinct sympathetic projections to brown fat regulate thermogenesis and glucose tolerance. Nat Metab (2026). https://doi.org/10.1038/s42255-025-01429-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s42255-025-01429-0

Brown adipose tissue differs fundamentally from white adipose tissue not only in color but in function, primarily through its expression of uncoupling protein 1 (UCP1) that enables heat generation. This thermogenic capacity enables brown fat to expend energy, a process critical for maintaining body temperature and systemic energy balance. Understanding the endogenous mechanisms that modulate BAT activity is therefore a cornerstone in metabolic research. Prior to this study, the molecular pathways shaping brown fat metabolism, especially at the local tissue level, were incompletely characterized. The identification of Neuritin 1 in this context addresses a major knowledge gap, providing fresh insights into the molecular circuitry driving BAT function.

Neuritin 1, previously studied predominantly in the nervous system where it modulates synaptic plasticity and neuronal survival, is now implicated in an entirely different physiology. The research reveals that Neuritin 1 acts as an intrinsic metabolic regulator in brown adipose tissue, influencing metabolic pathways that govern energy expenditure. The authors utilized a combination of transcriptomic analyses, protein expression profiling, and functional assays to demonstrate that Neuritin 1 expression is enriched in BAT compared to other adipose depots and that its presence is dynamically regulated in response to metabolic stressors such as cold exposure.

Mechanistically, Neuritin 1 appears to orchestrate a network of signaling pathways that enhance mitochondrial biogenesis and respiratory capacity within brown adipocytes. Detailed examination revealed that Neuritin 1 positively influences the expression of thermogenic genes and augments mitochondrial oxidative phosphorylation. This effect was demonstrated both in vitro, using cultured brown adipocytes, and in vivo, through genetic mouse models engineered to modulate Neuritin 1 expression. Mice with elevated Neuritin 1 in BAT exhibited increased energy expenditure and resistance to diet-induced obesity, underscoring the protein’s functional relevance.

The study also delved into the molecular underpinnings of Neuritin 1’s action, highlighting its ability to interact with key signaling molecules involved in metabolic regulation, such as AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). This interaction suggests Neuritin 1 may serve as an upstream modulator that integrates environmental cues and cellular energy demands to fine-tune brown fat’s thermogenic output. Such findings deepen our understanding of how intracellular communication networks coordinate adaptive metabolic responses.

One of the more striking findings was the modulation of Neuritin 1 expression by environmental and physiological stimuli known to activate BAT, such as cold exposure and β-adrenergic signaling. Neuritin 1 levels rose significantly upon cold challenge, correlating temporally with increased thermogenic gene expression. This responsiveness positions Neuritin 1 as a potential molecular switch that enhances brown fat activity in response to external environmental stimuli, providing a compelling link between sensory adaptation and metabolic control.

From a translational perspective, targeting Neuritin 1 or its downstream signaling pathways offers exciting therapeutic potential. The enhancement of BAT function has long been proposed as a strategy to counteract obesity by increasing energy expenditure. However, prior attempts have been hampered by the lack of specific regulators that can be safely modulated. Neuritin 1’s tissue-specific expression and defined role in brown adipose metabolism present a promising target for pharmacological intervention aimed at boosting endogenous thermogenic capacity without systemic side effects.

Moreover, this discovery invites a broader reconsideration of the role of neural factors in metabolic tissues beyond their classical contexts. The crossover between neurobiology and metabolism suggested by Neuritin 1’s dual functionality opens new interdisciplinary vistas for research. It also prompts investigation into whether other neurotrophic factors or neural modulators similarly influence adipose tissue physiology or systemic energy homeostasis, potentially unveiling a wider network of neurometabolic regulators.

The research employed state-of-the-art techniques to dissect Neuritin 1’s role, including loss-of-function and gain-of-function genetic models, advanced metabolomics, and high-resolution imaging of mitochondrial dynamics. These methodologies provided a comprehensive view of how Neuritin 1 impacts cellular bioenergetics and structural integrity of brown adipocytes. Complementary human tissue analyses indicated that Neuritin 1 is also present in human brown fat depots, suggesting translational relevance and the possibility that modulation of this protein could be beneficial in clinical settings.

In addition to metabolic regulation, the study hinted at Neuritin 1’s involvement in brown adipose tissue remodeling and plasticity. Brown fat is known for its remarkable capacity to expand and recruit new thermogenic adipocytes in response to chronic cold or pharmacological stimuli. Neuritin 1 may contribute to this adaptability by influencing adipocyte differentiation and survival, promoting a functional and metabolically active BAT milieu. This dimension adds complexity to the protein’s role and suggests it may support both acute thermogenic responses and longer-term tissue homeostasis.

As global metabolic diseases continue their unchecked rise, fueled by sedentary lifestyles and caloric excess, insights into regulators like Neuritin 1 bring hope for innovative therapies. Current anti-obesity treatments are limited by efficacy or adverse effects, while lifestyle interventions struggle with adherence and sustainability. The therapeutic activation of brown adipose tissue represents a compelling strategy to increase energy expenditure naturally, and discoveries like this pave the way for new drug development paradigms.

The findings also underscore the importance of local tissue regulation in systemic metabolism. It becomes increasingly clear that adipose tissues are not mere fat storage sites but active endocrine and metabolic organs, capable of complex regulatory functions. Neuritin 1 exemplifies this local control—a molecule with specialized, tissue-specific effects that exert broad physiological consequences. This layered understanding may refine future approaches to metabolic disease management, favoring precision medicine approaches targeting specific tissues or cell types.

Looking ahead, several open questions emerge from this study. How exactly does Neuritin 1 interface with other known BAT regulators such as fibroblast growth factor 21 (FGF21) and irisin? Could Neuritin 1 levels serve as biomarkers for brown fat activity or metabolic health? Furthermore, the potential side effects of modulating Neuritin 1 pharmacologically must be thoroughly investigated, given its roles in neuronal function. These are critical considerations as the field moves towards clinical translation.

In sum, the identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue offers a paradigm shift in how scientists and clinicians understand energy metabolism and thermogenesis. This discovery integrates molecular biology with physiological adaptation, highlighting a novel neuro-metabolic nexus that may be harnessed to fight obesity and related metabolic disorders. The work of Sánchez-Feutrie and colleagues thus represents a landmark in metabolic research, with wide-reaching implications for health and disease.

Subject of Research: Brown adipose tissue metabolic regulation and role of Neuritin 1

Article Title: Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue

Article References:

Sánchez-Feutrie, M., Romero, M., Veiga, S.R. et al. Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue.
Nat Commun 16, 7033 (2025). https://doi.org/10.1038/s41467-025-62255-2

Image Credits: AI Generated

The human body’s response to cold is not merely a passive reaction but an actively regulated process involving multiple organ systems working in concert to preserve core temperature. Brown adipose tissue, distinguished by its abundance of mitochondria and ability to combust lipids through uncoupling protein 1 (UCP1), plays a pivotal role in this adaptive thermogenesis. While sympathetic nervous inputs have long been recognized as key activators of BAT, the current research illuminates an additional layer of regulation emanating from the liver via exosomal signaling.

Exosomes are nanoscale extracellular vesicles known to ferry molecular cargo—including microRNAs, proteins, and lipids—between cells. They have emerged as integral players in intercellular communication, often modulating physiological and pathological processes remotely. This study provides compelling evidence that cold stimuli provoke hepatocytes to release exosomes enriched with miR-293-5p, which are subsequently taken up by brown adipocytes. Once inside BAT cells, miR-293-5p orchestrates changes in gene expression that augment the transcription of thermogenic genes.

The researchers conducted extensive in vivo and in vitro experiments to delineate this pathway. Mice subjected to acute cold exposure exhibited a significant surge in circulating hepatocyte-derived exosomes carrying miR-293-5p. These vesicles preferentially homed to brown adipose depots, where intracellular delivery of miR-293-5p resulted in the upregulation of key transcription factors known to drive the thermogenic program, including PGC-1α and PRDM16. Notably, the administration of miR-293-5p mimics enhanced oxygen consumption rates and heat production in brown fat cells, confirming the functional consequence of this molecular signaling.

What distinguishes this pathway is its ability to extend the influence of the liver beyond its classical metabolic functions to actively modulate systemic energy expenditure. The liver, traditionally viewed primarily as a hub for glucose and lipid metabolism, emerges here as a crucial endocrine organ with an active role in thermogenic regulation. The induction of a cold-specific exosomal signature suggests a sophisticated mode of organ crosstalk fine-tuned by environmental stimuli.

To understand the transcriptional landscape influenced by miR-293-5p, RNA sequencing of brown adipocytes treated with the hepatocyte-derived exosomes was performed. The results revealed broad transcriptional reprogramming consistent with enhanced mitochondrial biogenesis and fatty acid oxidation pathways. The upregulation of oxidative phosphorylation components and mitochondrial uncoupling machinery aligns with the observed thermogenic phenotype. Importantly, the modulation of these pathways offers a potential therapeutic target for metabolic diseases characterized by impaired energy balance, such as obesity and type 2 diabetes.

Further mechanistic investigation pinpointed that miR-293-5p directly represses regulatory elements that normally inhibit brown fat thermogenesis. This relief of transcriptional repression facilitates the activation of a complex gene network governing energy dissipation. Moreover, blocking the release of hepatocyte exosomes or silencing miR-293-5p in vivo led to blunted thermogenic responses and decreased cold tolerance, underscoring the physiological relevance of this inter-organ signaling axis.

The implications of this study extend beyond basic physiology into clinical contexts. Harnessing exosome-mediated delivery of specific microRNAs like miR-293-5p could become a novel strategy to enhance brown fat activity and combat metabolic diseases. Additionally, the identification of cold-induced exosomal signatures opens avenues for biomarkers reflective of thermogenic capacity and metabolic health. These findings highlight the potential for modulating exosomal communication as a paradigm-shifting therapeutic avenue.

The study also raises intriguing questions about the integration of nervous and endocrine signals in orchestrating the body’s response to cold. While sympathetic innervation remains critical for BAT activation, it is evident that exosomal cargo from the liver provides an ancillary, possibly synergistic, regulatory input. Deciphering how these signals are coordinated may reveal multilayered feedback loops essential for maintaining homeostasis under environmental challenges.

Technological advances underpinning this study were pivotal in capturing the subtle but functionally critical exosomal cargo changes induced by cold stress. The use of high-resolution sequencing and sensitive vesicle isolation techniques allowed precise characterization of miRNA profiles within circulating exosomes. Coupled with genetically modified mouse models and real-time metabolic assessments, the research presents a comprehensive mechanistic picture with translational potential.

Another significant takeaway is the context-dependent nature of exosome biogenesis and cargo loading. The selective enrichment of miR-293-5p within hepatocyte exosomes upon cold exposure suggests dynamic regulation of RNA packaging dependent on physiological states. This adaptability might reflect an evolutionary advantage, enabling swift systemic adjustment to environmental perturbations.

In the broader scope of metabolic research, this study enriches our understanding of how organ crosstalk fine-tunes energy balance beyond the classical hormonal realm. It invites a reconsideration of the liver’s role from a metabolic workhorse to a master regulator capable of dispatching molecular messengers that guide remote tissues. The identification of miR-293-5p as a key thermogenic driver adds a crucial piece to the puzzle of metabolic homeostasis.

The work also encourages exploration into whether similar exosomal communications exist between other organs in response to diverse stressors. If so, therapeutic modulation of these vesicular networks could revolutionize treatment options across a spectrum of diseases, including those related to inflammation, cancer, and neurodegeneration, where intercellular messaging is pivotal.

Looking ahead, elucidating the full repertoire of hepatocyte-derived exosomal contents and their respective targets in peripheral tissues will be essential. Integrative ‘omics’ approaches, combined with functional assays and clinical studies, could map a comprehensive inter-organ communication network, transforming our strategies for managing metabolic health.

In conclusion, the discovery that cold-induced hepatocyte-derived exosomes modulate brown adipose thermogenesis via miR-293-5p-mediated transcriptional reprogramming represents a paradigm shift. It reveals an elegant molecular dialogue between liver and brown fat, emphasizing the significance of exosome-mediated signaling in adaptive thermogenesis. This insight not only deepens our understanding of energy metabolism but also holds promise for innovative interventions addressing obesity and metabolic syndrome.

Subject of Research:
Cold-induced hepatocyte-derived exosomes mediate brown adipose tissue thermogenesis through microRNA-driven transcriptional changes.

Article Title:
Cold-induced hepatocyte-derived exosomes activate brown adipose thermogenesis via miR-293-5p-mediated transcriptional reprogramming.

Article References:
Gao, X., Xu, J., Xu, Z. et al. Cold-induced hepatocyte-derived exosomes activate brown adipose thermogenesis via miR-293-5p-mediated transcriptional reprogramming. Cell Death Discov. 11, 396 (2025). https://doi.org/10.1038/s41420-025-02697-1

Image Credits:
AI Generated

DOI:
https://doi.org/10.1038/s41420-025-02697-1